Q32 Bio Inc. (LON:0T6G)
London
· Delayed Price · Currency is GBP · Price in USD 2.470
+0.019 (0.78%)
At close: Feb 21, 2025
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of 24.76 million as of February 21, 2025.
Market Cap
24.76M
Enterprise Value
-28.22M
Revenue
-10.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.47
Market Cap Chart
Since March 26, 2024, Q32 Bio's market cap has decreased from 157.73M to 24.76M, a decrease of -84.30%. That is a compound annual growth rate of -86.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 24.76M | -26.01% |
| Dec 31, 2024 | 33.47M | -78.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.54B |
| GSK plc | 58.32B |
| Haleon | 35.36B |
| Smith & Nephew | 9.01B |
| Hikma Pharmaceuticals | 5.12B |
| ConvaTec Group | 5.06B |
| HUTCHMED (China) | 2.19B |
| Genus | 1.17B |